Status
Conditions
Treatments
About
Inhalation pneumonia (PI) is common in clinical practice but is rarely studied. For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP. There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common. In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
60 participants in 3 patient groups
Loading...
Central trial contact
Jean-Philippe LANOIX, Dr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal